Synopsis Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a fr.....
SynopsisThe neutral displacement needleless connector for infusion therapy is designed to complement best clinical practices to help reduce the risk of catheter-related bloodstream infections (CRBSI) and reflux-induced catheter occlusions. The global Neutral Dis.....
SynopsisThe global Pancreatic Endocrine Tumor Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pancreatic Endocrine Tumor Drug in various end use industr.....
SynopsisThe global Percutaneous Nephrocentesis Kit market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered whi.....
Synopsis The global 3D Printing for Medical Device market size was valued at USD 1994.1 million in 2022 and is forecast to a readjusted size of USD 5895 million by 2029 with a CAGR of 16.7% during review period. The influence of COVID-19 and the Russia-U.....
Synopsis Global Sepharose Carboxyl Magnetic Beads market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and .....
SynopsisWastewater treatment is a process used to convert wastewater into an effluent that can be returned to the water cycle with minimum impact on the environment, or directly reused. The latter is called water reclamation because treated wastewater can then be used.....
SynopsisThe global Fluvoxamine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fluvoxamine in various end use industries. The expanding demands from the Depr.....
SynopsisThe global Blood Glucose Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blood Glucose Device in various end use industries. The expanding dem.....
SynopsisNoradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of antidepressants primarily used to treat depression. The global NaSSAs Antidepressants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030.....
